Table 1 Clinical and biochemical characteristics of T2D patients and controls
From: Identification and functional study of GATA4 gene regulatory variants in type 2 diabetes mellitus
Controls(n = 371) | T2D(n = 255) | P value | |
|---|---|---|---|
Age (years, mean ± SD) | 51.12 ± 12.52 | 53.00 ± 11.88 | 0.062 |
Male (n, %) | 197 (53.10%) | 138 (54.12%) | 0.807 |
Smoking (n, %) | 42 (11.32%) | 80 (31.37%) | 0.000 |
BMI (Kg/M2) | 25.11 ± 3.58 | 24.86 ± 3.56 | 0.438 |
Hypertension (n, %) | 94 (25.34%) | 97 (38.04%) | 0.001 |
SBP (mmHg) | 129.08 ± 21.12 | 132.28 ± 19.71 | 0.067 |
DBP (mmHg) | 78.26 ± 13.42 | 80.19 ± 11.89 | 0.075 |
TG (mmol/L) | 1.57 ± 1.10 | 1.66 ± 1.07 | 0.091 |
TC (mmol/L) | 5.02 ± 0.95 | 4.88 ± 1.09 | 0.227 |
HDL (mmol/L) | 1.27 ± 0.30 | 1.21 ± 0.53 | 0.359 |
LDL (mmol/L) | 2.91 ± 0.83 | 2.81 ± 0.86 | 0.127 |